Keywords: Finland, Fimea, Regulation, R&D, PIF

Finland’s pharma industry has great expectations for Fimea’s new role

Article | 13 November 2009

Starting its work as of the beginning of November, the Finnish Medicines Agency Fimea plays an important role for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in